Had they included just one of Tony Hoare’s achievements, many scientific careers would be considered prestigious enough. His had a long list, unfortunately closed by his passing away at the age of 92 ...

Pentagon's OPEN program to help set China-free minerals prices Four critical minerals to be AI model's first focus Program aims to help offset Chinese market interference Questions on how tariffs ...

NYU Langone’s decision comes amid Trump administration threats to cut funding to providers who treat trans youth NYU Langone Health, one of New York City’s major hospital networks, announced this week ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

The T32 grant provides full-time research training support for post-candidacy predoctoral learners pursuing mentored clinical and translational research or clinical and translational science who are ...

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. If you’ve ever searched for information online about the ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)-- Rallybio ...

Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – The REV102 program originated from a joint venture ...